Osteum
Designed by PubCompare.ai, Osteum enables users to easily locate and compare protocols from a vast database of literature, preprints, and patents.
By leveraging advanced AI techniques, Osteum identifies the best protocols and products to meet your specific research needs, streamlining your workflow and enhancing the efficiency of your experiments.
With Osteum, researchers can save time, reduce costs, and improve the quality of their findings.
Most cited protocols related to «Osteum»
All patients underwent surgery in general anesthesia after two days of preoperative intravenous antibiotic therapy with penicillin and metronidazole. Microbiological samples are taken at the time of initial contact with the patient and at the time of surgery when purulent drainage was visible. After elevating a mucoperiosteal flap using a crestal incision including areas of exposed bone, all the affected bone was removed with Luehr forceps and round burrs. Teeth in contact with the affected bone were removed, sharp bony edges rounded. After removal of the necrotic bone and thus opening of the maxillary sinus, polypoid mucosa was removed and the sinus was rinsed with iodine solution and xylometazoline. The sinus was endoscopically inspected. If the natural osteum was obstructed, it was widened with Weil’s forceps. The wound was closed using a multilayer technique previously described for the mandible and adapted for the maxilla [16 (link)]. In this technique, after slitting of the vestibular periosteum, its mobile part is quilted under the palatinal mucosa with absorbable backstitches. A second layer of absorbable backstitches is used to align the wound edges to one level and tighten the closure. A running suture brings the mucosal edges together and closes the wound (Figs.
Schematic drawing of the technique
Clinical example of the necrosotomy and wound closure
Postoperative controls were carried out for removal of sutures and then every six months. When recall in our unit was not feasible (e.g. distant place of residence) controls were carried out by the local dentist.
Cold ischemia time was defined as time since aortic clamping and starting of perfusion by chilled perfusion fluid solution till the time of opening of vascular clamps during recipient surgery. Delayed graft function was defined as need for dialysis in first week after transplantation. Induction immunosuppressant regime was based on cyclosporine in first five cases of transplantation from heart-beating brain-dead donors, and, antithymoglobulin in all others. Maintenance immunosuppressant regime was based on cyclosporine/tacrolimus, steroids, and mycofenolate mofetil in all patients.
Most recents protocols related to «Osteum»
(NaCl), trifluoroacetic acid (TFA), lactic acid, calcium chloride
(CaCl2), hydrochloric acid (HCl, 36%), acetonitrile (ACN),
urea (NH2CONH2), aminodiacetic acid (HN(CH2COOH)2), ammonia solution (NH4OH, 25%),
methyl cellulose (MC, viscosity: 1500 cP), and sodium hydroxide (NaOH)
were all purchased from Sigma-Aldrich (USA). Acetic acid and phosphoric
acid (85 wt %) were brought from Merck (USA); sinapic acid (SA) was
provided by Supelco (USA). The amphoteric electrolytes: Pharmalyte
3–10 carrier ampholytes were purchased from Cytiva (USA). The
pI markers (pH = 5.500 and 3.210) were purchased from AB Sciex (USA)
and AES (Canada). The tris(hydroxymethyl)aminethane (THAM) solution
of 1 M was purchased from Thermo Fisher (USA). Lactoferrin (L9507),
α-lactalbumin (L5385), β-lactoglobulin (L3908), bovine
serum albumin (BSA), α-casein (C6780), β-casein (C6905),
κ-casein (C0406), and lysozyme (L6876) were all purchased from
Sigma-Aldrich (USA). Casein glycomacropeptide (CGMP) was provided
by Agropur (BiPRO GMP 9000). Casein phosphopeptides (CPP) were provided
by Ingredia Nutritional (OSTEUM CPP). All of the reagents were directly
used for experiments without further purification.
The cIEF
gel was obtained by mixing 15 mL of ultrapure water and 0.4 g of MC
powder, followed by stirring for 5 min at 80 °C. After the mixture
was removed from the heater, an ice–water mixture was added
to the solution to 40 mL. Then, the solution was stirred every 30
min until cooling to −20 °C. Then, the obtained mixture
was stored at 4–8 °C overnight. Furthermore, 3 M urea
gel solution was prepared by dissolving 1.8 g of urea and 6 mL of
cIEF gel with ultrapure water added, meeting a final volume of 10
mL. After mixing, the as-prepared solution was stored at 4 °C.
A prospective study was performed that involved patients with a diagnosis of isolated sphenoid sinusitis. In total, 59 people, aged 4–68 years, took part in the study. The study was conducted in the pediatric department and in the adult department of otorhinolaryngology. In order to provide case-control research in the field of isolated bacterial sphenoid sinusitis, the exclusion criteria from this research were neoplasm, intracranial involvement of pathological process, pregnancy, and a history of previous ISS [13 (link)].
In all cases, patients were admitted to the hospital with subtotal opacification of one or both sphenoid sinuses, and normal pneumatization in others. All patients were admitted to our department on an emergency basis, and the only available rapid diagnostic method that we had was CT. In the event of a diagnosis, we did not repeat the MRI. Patients who had an MRI were referred to us for emergency hospitalization from neurologists and ophthalmologists. At the initial stage, all patients had the same medical therapy (systemic decongestant, systemic antibacterial therapy, topical glucocorticosteroids, oral corticosteroids and nose irrigation) [14 (link),15 (link)].
Irrigation included the special technique that used the Dolphin system, which allows the delivery of the saline solution to the sinus (
Then, after 14 days, the dynamics of treatment were assessed with the use of computed tomography of the paranasal sinuses [16 (link),17 (link)].
Patients with good outcomes after the treatment, which included residual edematous changes of the sinus mucosa on the CT scan, were designated as group 1 of the study (
Patients whose CT scan results did not differ from the initial data nor showed negative dynamics such as involvement in the inflammatory process of posterior ethmoidal cells on the affected site, were referred for surgical treatment (endoscopic sphenoidotomy) [19 (link)]. These patients constituted group 2 of the study, and named the ineffective conservative treatment group. In total, the second group included 37 patients aged from 4 to 68 years old.
The control group consisted of patients who had no pathological changes according to CT scans. The last group consisted of 33 patients aged 8–70 years. These were patients who underwent CT scans because of ophthalmological indications. Most of them had dacryostenosis, and contrasting of the lacrimal pathways. It was these patients who had no nasal complaints and underwent CT.
All subjects of groups 1 and 2 underwent a comprehensive examination, which included:
Otorhinolaryngological examination (n = 59).
Rigid endoscopy of the nasal cavity and nasopharynx (n = 59).
Computed tomography of the paranasal sinuses (n = 92).
Magnetic resonance imaging of the paranasal sinuses (n = 6)
Bacteriological examination from the sphenoid sinus directly (n = 37).
Bacteriological examination of the nasal cavity mucus (n = 37).
Measurement of the sphenoid sinus volume (before surgery/ during the surgery (n = 12)) [20 (link)].
Measurement of the new formed sphenoid sinus osteum square (n = 37) [21 ].
Four models were constructed and analyzed: a step-by-step method of eliminating predictors, and a step-by-step method for including predictors, each considered with and without constant inclusion. As a result, the model built by the method of successive inclusion showed the greatest significance. This version of the model was chosen for construction by the forced inclusion method. The quality of the constructed model was determined by the Nagelkerke coefficients [22 (link),23 ,24 (link),25 (link),26 (link)].
Data source
The data collected in this study were extracted from an existing database of 269 patients of a single surgeon operating at two tertiary referral teaching hospitals (Concord General Repatriation Hospital and Liverpool Hospital, Sydney, NSW) and two private hospitals (Sydney Private Hospital and Macquarie University Hospital, Sydney NSW) from 2007 until 2019. The data had been previously collected in a contemporaneous fashion as part of an ongoing audit of patients undergoing glaucoma surgery (trabeculectomy or phacotrabeculectomy).
Eligibility criteria
Patients with primary open-angle glaucoma, angle-closure glaucoma, normal-tension glaucoma, and pseudoexfoliation glaucoma who had undergone trabeculectomy or phacotrabeculectomy with at least five years of follow-up data were included in the study. Exclusion criteria were patients who had their procedure less than five years ago, patients who have had previous ophthalmic procedures, and patients with secondary glaucoma associated with increased risk of trabeculectomy failure including uveitic, pigmentary, traumatic, and neovascular glaucoma. Because these eyes are recognized to be at increased risk of surgical failure, they were unlikely to be offered phacotrabeculectomy in any case, and thus would be unhelpful in comparing the two procedures [14 ]. Since eyes with exfoliation syndrome tend to do well with trabeculectomy, and by extension phacotrabeculectomy, this was the one secondary glaucoma that was eligible for inclusion [15 ]. Both eyes of eligible patients were included in the study if they otherwise met the inclusion criteria.
Patient visits
Baseline demographic information collected includes age, gender, race, past medical and surgical history. Baseline ocular information collected included glaucoma diagnosis, operated eye, best-corrected visual acuity (BCVA), IOP, presence of visual field defect and mean deviation (MD) on visual field testing, number of glaucoma medications, lens status, and previous ocular surgery.
Post-operative data collected at one year, two years, and five-year time points were BCVA, IOP, a number of glaucoma medications, complications, need for re-operation, and bleb morphology. The one and two-year time points were selected to show shorter-term progress and the five-year time point was selected to show longer-term progress.
Outcome measures
The primary outcome measure was IOP. In addition, a target IOP was determined clinically based on the patient’s stage of glaucoma pre-operatively and was not changed depending on the procedure. When post-operative IOP data were collected at the various time points during follow-up, a note was made whether target IOP was achieved in addition to the numerical IOP value.
Secondary outcome measures included a number of glaucoma medications, treatment success rates, best-corrected visual acuity, bleb morphology outcome, post-operative complications, and re-operations.
The criterion for decreased visual acuity was a decrease in two or more lines of Snellen acuity from baseline at the post-operative time points. Treatment failure was defined as not achieving the desired target IOP, repeat operation for glaucoma (excluding bleb needling), or the development of serious complications. Absolute success was defined as achieving the target IOP without glaucoma medications or vision-threatening complications. Qualified success was defined as achieving the target IOP with the additional use of glaucoma medications. Bleb morphology was documented via the Indiana Bleb Appearance Grading Scale [16 (link)]. Further re-operations documented include needling, repeat glaucoma surgery, surgery for post-operative complications, and cataract surgery.
Statistical analysis
Univariate comparisons between treatment groups were performed with the two-sided Student t-test for continuous variables. A P-value of 0.05 or less was considered statistically significant in the analysis. Treatment comparisons of the cumulative proportion of treatment success were assessed with the stratified Kaplan-Meier survival analysis log-rank (Mantel-Cox) test using the GraphPad PrismTM software (GraphPad Software, CA).
Surgical methods
All surgeries were performed by or under the supervision of a single surgeon. The selection of patients to have a combined procedure was determined by the surgeon, taking into consideration the degree of visual impairment from the cataract, co-existent narrow-angle component attributable to the cataract, and pre-operative assessment of the risk of trabeculectomy failure.
Surgery was generally performed under local anesthesia with peribulbar or Sub-Tenon’s block, and in some cases under general anesthesia depending on patients’ preferences and ability to tolerate the procedure. A fornix-based conjunctival flap was used for all cases, with a rectangular 5-6 x 3-4 mm half-thickness scleral flap. An anti-fibrotic regimen was selected based on the anticipated risk of postoperative scarring. Most patients received MMC applied on five sponges into the subconjunctival space after the scleral flap was fashioned but prior to entry into the anterior chamber. Doses of 0.2-0.4 mg/ml were used for 2-3 mins. Some cases with minimal risk factors for post-operative scarring received 5-FU on sponges (50 mg/ml) rather than MMC. All cases of combined phacotrabeculectomy received MMC. An anterior chamber maintainer was used for most cases of standalone trabeculectomy. A single punch osteum with Khaw punchR (750 µm) was used to create the osteum under the scleral flap and surgical iridectomy was performed with Vannas scissors. A combination of preplaced 10-0 nylon releasable and adjustable sutures was used to close the scleral flap. The conjunctiva was closed with 10-0 nylon sutures at the limbus and 8-0 vicryl sutures on either side if relaxing incisions in the peritomy were required during surgery.
In cases of combined phacotrabeculectomy, a 2-site approach was used with a separate temporal clear corneal incision for the phacoemulsification with a posterior chamber lens implant. A standard one-piece acrylic hydrophilic monofocal lens was implanted in the capsular bag for all cases. The corneal wound was sutured with 10-0 nylon and ensured to be watertight, and the pupil was constricted with acetylcholine chloride intraocular solution (MiocholTM) prior to performing the trabeculectomy.
All patients received a drop of atropine 1% at the end of the case. Post-operatively patients were treated with chloramphenicol drops four times a day for one week, and intensive topical dexamethasone 0.1% eye drops four times a day for over six to eight weeks. Drop frequency and duration were titrated to the degree of conjunctival vascularity and inflammation observed at post-operative visits.
A curvilinear skin incision of 10 to 15 mm, corresponding to anterior lacrimal crest was made, care being taken to avoid trauma to the angular vein. Blunt dissection of the orbicularis and exposure of the lacrimal sac was done.
In Arrugas Bone trephine assisted Flapless DCR with COS-MMC technique (Group A), the sac was identified followed by its anterior and posterior part being excised, leaving a small collar around the common internal opening (Figure 1a, 1b) . The area around the common internal opening was handled carefully so as to not damage it. A bony osteum of 10 mm using Arrugas bone trephine (size 10mm) was made in the lateral nasal wall (Figure 1c). A corresponding part of nasal mucosa was then removed along with bone so that the internal common opening was facing the nasal cavity (Figure 1d, 1e) . A circumosteal intramucosal injection of 0.02% MMC (0.1 ml) was given along the margin of the ostium at four places each (Figure 1g,1h). The anterior remaining small collar of the sac was sutured along with orbicularis muscle and the subcutaneous tissue with 6-0 vicryl (Ethicon Inc.). Skin was opposed using 6-0 mersilk. Post operatively all patients were given oral and local antibiotics along with nasal decongestants for 1 week . The stitches were removed ten days post surgery. Follow ups were done on day one and seven and thereafter at the end of one month, three month, and one year respectively from the day of surgery. At each visit, irrigation with sterile saline was done and cases were examined for any complications such as wound gap, infection, discharge and epistaxis. Surgical success was defined by anatomical patency of the lacrimal drainage system on irrigation. Institute ethical committee clearance was taken and the tenets of Helsinki were adhered to. Statistical analysis was performed using SPSS software. Significance was defined as p<0.05.
Demographics and baseline characteristics were summarized using descriptive statistics.
Categorical variables were summarized using frequencies and percentages. To compare the categorical variables between groups, the chisquare test was used to assess if differences exist. 3).
The escape room consisted of four radiological ‘puzzles’ (relating to the objectives above), that could be solved in any order (Figs.
‘Read the signs’: an example of one of the puzzles in the escape room.
‘Location, location, location’: another example of a puzzle in the escape room. The participants need to identify whether a chest radiograph is normal or abnormal. If abnormal, then the location of the consolidation should be determined and matched to the number code given in the box in the bottom left corner of the poster. For example, in this game, the three number combination is 2, 6 and 1
‘Diagnose Doctor Perry Osteum’: another example of a puzzle in the escape room.
‘Radiation dosages’ puzzle: In this puzzle (
Equipment in the escape room.
Crossword puzzle.
The layout of the escape room. The puzzles listed in Figs.
Top products related to «Osteum»
More about "Osteum"
This innovative tool leverages advanced machine learning techniques to enable users to easily locate, compare, and optimize the protocols from a vast database of scientific literature, preprints, and patents.
Designed to enhance the efficiency and quality of research workflows, Osteum empowers scientists to quickly identify the best protocols and products to fit their specific needs.
By automating the process of protocol selection and comparison, Osteum saves researchers valuable time and reduces the costs associated with experimental optimization.
The platform's AI-driven capabilities can analyze a wide range of experimental parameters, including methodologies, reagents, and expected outcomes, to provide personalized recommendations.
This allows researchers to make informed decisions and improve the overall quality of their findings.
Osteum's user-friendly interface makes it easy to navigate the extensive database of protocols, enabling researchers to quickly find the most relevant and effective solutions for their projects.
Whether you're working on a new line of research or refining an existing experimental approach, Osteum is a powerful tool that can help streamline your workflow and enhance the efficiency of your experiments.
With its advanced AI technology and comprehensive protocol database, Osteum is revolutionizing the way researchers optimize their experimental protocols, leading to more efficient and impactful scientific discoveries.